CD
AGN

Christopher Davis’s Allergan plc AGN Stock Holding History

Christopher Davis’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,100
Closed -$571K – 201
2015
Q3 		$571K Hold
2,100
– – ﹤0.01% 181
2015
Q2 		$637K Buy
+2,100
New +$626K ﹤0.01% 177

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Christopher Davis's AGN Position: Q4 2015 in Review

Christopher Davis sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 2,100 shares — an estimated $571K sold.

Christopher Davis first reported a position in AGN in Q2 2015 and held it in 2 quarters. The position peaked at $637K in Q2 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Christopher Davis reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Christopher Davis sold 2,100 Allergan plc shares in Q4 2015, an estimated $571K.
  • Christopher Davis first reported a position in Allergan plc in Q2 2015 and held it in 2 quarters.
  • Christopher Davis's Allergan plc position peaked at $637K in Q2 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Davis Selected Advisers's 13F filing for Q4 2015, filed 12 Feb 2016.